Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NYMXF Relative to the S&P 500

NYMXF Relative to the Sector

Seasonal Chart Analysis

Analysis of the Nymox Pharmaceutical Corp. (OTCMKT:NYMXF) seasonal charts above shows that a Buy Date of August 1 and a Sell Date of October 24 has resulted in a geometric average return of 24.92% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 50.81% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

To download NYMXF seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NYMXF